Experience

We advised the underwriters on the public equity offering

We advised the joint book-running managers on the public offerings of stock and convertible notes

We advised the underwriters on the IPO of ADSs

We advised the joint book-running managers on the public equity offering

Davis Polk advised the representatives of the underwriters in connection with the $75 million SEC-registered follow-on offering of 9,343,750 ordinary shares of Gamida Cell Ltd, which…

Davis Polk advised the placement agent in connection with a private placement pursuant to Rule 4(a)(2) by Solid Biosciences Inc. of $90 million of common stock. Solid Biosciences Inc…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $175 million SEC-registered common stock and pre-funded warrants…

Davis Polk advised the representatives of the several underwriters in connection with an initial public offering of 10,592,106 shares of Class A common stock of Seer, Inc. at $19.00 per…

Davis Polk advised the joint book-running managers in connection with the $297.9 million secondary offering of 6,477,293 shares of common stock of Oak Street Health, Inc. by certain…

Davis Polk advised the underwriter in connection with the $340 million SEC-registered offering of 1,511,546 American depositary shares of BeiGene, Ltd. by certain existing ADS holders. The…